glutathione & neurology Unlocking the Potential of Intravenous
Description
involved treating four cynomolgus monkeys with the nucleotide analog bromodeoxyuridine (BrdU) for 4 weeks, identifying cells with long-term retention of BrdU and OCT4 immunoreactivity
However, this extrapolation from one organ to another is questionable as the exposure levels, the phase I metabolic capacity to generate NAPQI, the phase II metabolic capacity to eliminate APAP, and potential adaptive mechanisms in response to an APAP-induced cellular stress are not well described in the CNS system
Digunakan oleh: Dewasa
Talanta 131, 693705
